NCT02077023|Completed
Loading search results
Sponsor study identifier
observational
456
1 country
1
Study Start
February 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
May 2019
Actual (reported)Study Completion
May 2019
Actual (reported)The purpose of the study is to estimate the contemporary prevalence of cardiovascular diseases in the United Kingdom (UK) and to describe the incidence and prevalence of stroke, mini stroke (TIA), Heart Attack (MI), deaths and interventions repairs for carotids and occlusive arterial disease in a large population. This study will also allow us to obtain reliable information on the age- and sex-specific relevance of tobacco and alcohol consumption, obesity, diabetes and blood pressure as risk factors for different cardiovascular diseases. By following up a large group of participants for 5 years, we will be able to estimate the annual risk of stroke and other CVD events associated with asymptomatic carotid artery stenosis and atrial fibrillation.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 2019
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 2014
Date type not reportedThis date has not been verified as actual or estimated.
February 5, 2014
Actual (reported)March 4, 2014
Actual (reported)May 2019
Actual (reported)May 2019
Actual (reported)The contemporary prevalence of asymptomatic carotid artery disease and atrial fibrillation by age and sex and natural history of stroke associated with asymptomatic carotid lesion and atrial fibrillation identified by screening
5 years
Effect of a targeted, comprehensive and cost-effective cardiovascular screening programme on a number of participants with adverse events
1 year
The study consists of an observational, prospective study of the prevalence of and risk factors for AF, CAS and stroke amongst 5,200 people who voluntarily attended cardiovascular screening appointments provided by Life Line Screening. This cohort will include 1300 participants who are exposed to significant carotid artery stenosis (more than 50% artery occlusion identified by ultrasound scan) and atrial fibrillation. We also aim to recruit 3900 participants who do not have carotid artery disease or atrial fibrillation as control group and for comparison purposes. The control group will be drawn from a population that is similar to the exposed group in all respects other than their carotid disease and atrial fibrillation. The data collected for the control group will be the same and will be obtained in the same way as those on the exposed group.
Imperial College London
London, SW7 2AZ, United Kingdom
Mohssen Chabok, MD
Imperial College London
Mohammed Aslam, PhD
Imperial College London
456 participants (actual enrollment reported by the registry).
First Submitted
February 5, 2014
First Posted
March 4, 2014
Study Start
February 2014
Date type not reportedThis date has not been verified as actual or estimated.
The Brain Heart Interaction in Acute Stroke
Contact the study team to confirm eligibility.
Primary Completion
May 2019
Actual (reported)Study Completion
May 2019
Actual (reported)Last Updated
June 12, 2019
Record last verified: 2019-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: